Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2019 Jul 18;9:709. doi: 10.3389/fonc.2019.00709

Erratum: ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

Frontiers Production Office1,*
PMCID: PMC6657735  PMID: 31380291

Due to a production error, the affiliation for Antonio G. Naccarato was incorrectly given as the “Department of Cell and Developmental Biology, the Hebrew University of Jerusalem, Jerusalem, Israel” (affiliation 8). The correct affiliation is the “Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, Pisa, Italy” (affiliation 10).

The publisher apologizes for this mistake. The original article has been updated.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES